STF Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $626K | Buy |
8,961
+234
| +3% | +$16.4K | 0.25% | 79 |
|
2025
Q1 | $641K | Buy |
8,727
+5
| +0.1% | +$368 | 0.31% | 73 |
|
2024
Q4 | $571K | Buy |
8,722
+236
| +3% | +$15.5K | 0.26% | 82 |
|
2024
Q3 | $661K | Sell |
8,486
-768
| -8% | -$59.8K | 0.3% | 68 |
|
2024
Q2 | $722K | Sell |
9,254
-441
| -5% | -$34.4K | 0.3% | 65 |
|
2024
Q1 | $657K | Sell |
9,695
-125
| -1% | -$8.47K | 0.28% | 76 |
|
2023
Q4 | $661K | Buy |
9,820
+325
| +3% | +$21.9K | 0.31% | 70 |
|
2023
Q3 | $643K | Buy |
9,495
+5,633
| +146% | +$381K | 0.34% | 66 |
|
2023
Q2 | $276K | Sell |
3,862
-3,104
| -45% | -$222K | 0.3% | 65 |
|
2023
Q1 | $484K | Buy |
6,966
+2,895
| +71% | +$201K | 0.33% | 63 |
|
2022
Q4 | $276K | Buy |
+4,071
| New | +$276K | 0.4% | 58 |
|